These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients. Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342 [TBL] [Abstract][Full Text] [Related]
24. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses. Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512 [TBL] [Abstract][Full Text] [Related]
25. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis. Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H Front Immunol; 2018; 9():3099. PubMed ID: 30687316 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
27. Circulating microRNAs as biomarkers for Sepsis secondary to pneumonia diagnosed via Sepsis 3.0. Zhang W; Jia J; Liu Z; Si D; Ma L; Zhang G BMC Pulm Med; 2019 May; 19(1):93. PubMed ID: 31088429 [TBL] [Abstract][Full Text] [Related]
28. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer. Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174 [TBL] [Abstract][Full Text] [Related]
29. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
30. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
31. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
32. Circulating microRNAs associated with C-type natriuretic peptide in childhood obesity. Cabiati M; Randazzo E; Salvadori C; Peroni D; Federico G; Del Ry S Peptides; 2020 Nov; 133():170387. PubMed ID: 32828851 [TBL] [Abstract][Full Text] [Related]
33. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction. Li H; Zhang P; Li F; Yuan G; Wang X; Zhang A; Li F Biomed Res Int; 2019; 2019():5012648. PubMed ID: 31179325 [TBL] [Abstract][Full Text] [Related]
34. Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults. Červinek L; Mayer J; Doubek M Int J Hematol; 2015 Jul; 102(1):7-11. PubMed ID: 25833724 [TBL] [Abstract][Full Text] [Related]
35. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients. Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580 [TBL] [Abstract][Full Text] [Related]
36. Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia. Garabet L; Ghanima W; Monceyron Jonassen C; Skov V; Holst R; Mowinckel MC; C Hasselbalch H; A Kruse T; Thomassen M; Liebman H; Bussel JB; Sandset PM Platelets; 2019; 30(2):206-212. PubMed ID: 29215956 [TBL] [Abstract][Full Text] [Related]
37. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis. Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627 [TBL] [Abstract][Full Text] [Related]
38. [Expression Analysis of miRNA Profiles in Apheresis Platelets during Storage]. Wang YQ; Zhuang YL; Qiao MM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):256-263. PubMed ID: 35123637 [TBL] [Abstract][Full Text] [Related]
39. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794 [TBL] [Abstract][Full Text] [Related]
40. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer. Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]